COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
---|---|---|---|---|---|---|---|
BREAST | 337 | 9 | 470 | 47 | 572 | 101 | 615 |
ERLYTX | 40 | 0 | 0 | 5 | 61 | 8 | 49 |
GI | 216 | 2 | 104 | 17 | 207 | 36 | 219 |
GU | 539 | 11 | 574 | 48 | 584 | 94 | 572 |
LEUK | 54 | 3 | 157 | 8 | 97 | 11 | 67 |
LUNG | 835 | 16 | 835 | 73 | 889 | 131 | 797 |
LYMPH | 200 | 5 | 261 | 26 | 317 | 45 | 274 |
MELAN | 454 | 5 | 261 | 28 | 341 | 84 | 511 |
MMYEL | 198 | 3 | 157 | 19 | 231 | 50 | 304 |
MULT | 23 | 1 | 52 | 3 | 37 | 11 | 67 |
OTHER | 63 | 1 | 52 | 7 | 85 | 15 | 91 |
PREV | 4 | 0 | 0 | 0 | 0 | 1 | 6 |
SXQOL | 6 | 0 | 0 | 0 | 0 | 2 | 12 |
Total | 2969 | 56 | 2923 | 281 | 3421 | 589 | 3584 |
COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
---|---|---|---|---|---|---|---|
CCD | 900 | 8 | 417 | 73 | 889 | 132 | 804 |
ERLYTX | 10 | 0 | 0 | 1 | 12 | 2 | 12 |
GI | 3 | 0 | 0 | 1 | 12 | 3 | 18 |
GU | 6 | 0 | 0 | 1 | 12 | 5 | 30 |
LEUK | 5 | 0 | 0 | 1 | 12 | 5 | 30 |
LUNG | 341 | 7 | 365 | 35 | 426 | 60 | 365 |
OTHER | 9 | 0 | 0 | 1 | 12 | 3 | 18 |
PEOLC | 12 | 0 | 0 | 0 | 0 | 0 | 0 |
PREV | 535 | 4 | 209 | 24 | 292 | 44 | 268 |
SURV | 11 | 0 | 0 | 2 | 24 | 4 | 24 |
SXQOL | 1360 | 13 | 678 | 50 | 609 | 92 | 560 |
Total | 3192 | 32 | 1669 | 189 | 2300 | 350 | 2129 |
COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
---|---|---|---|---|---|---|---|
BREAST | 337 | 9 | 470 | 47 | 572 | 101 | 615 |
CCD | 900 | 8 | 417 | 73 | 889 | 132 | 804 |
ERLYTX | 50 | 0 | 0 | 6 | 73 | 10 | 61 |
GI | 219 | 2 | 104 | 18 | 219 | 39 | 237 |
GU | 545 | 11 | 574 | 49 | 597 | 99 | 603 |
LEUK | 59 | 3 | 157 | 9 | 110 | 16 | 97 |
LUNG | 1176 | 23 | 1200 | 108 | 1315 | 191 | 1163 |
LYMPH | 200 | 5 | 261 | 26 | 317 | 45 | 274 |
MELAN | 454 | 5 | 261 | 28 | 341 | 84 | 511 |
MMYEL | 198 | 3 | 157 | 19 | 231 | 50 | 304 |
MULT | 23 | 1 | 52 | 3 | 37 | 11 | 67 |
OTHER | 72 | 1 | 52 | 8 | 97 | 18 | 110 |
PEOLC | 12 | 0 | 0 | 0 | 0 | 0 | 0 |
PREV | 539 | 4 | 209 | 24 | 292 | 45 | 274 |
SURV | 11 | 0 | 0 | 2 | 24 | 4 | 24 |
SXQOL | 1366 | 13 | 678 | 50 | 609 | 94 | 572 |
Total | 6161 | 88 | 4592 | 470 | 5723 | 939 | 5716 |
COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
---|---|---|---|---|---|---|---|
BREAST | 205 | 4 | 209 | 32 | 390 | 58 | 353 |
ERLYTX | 31 | 0 | 0 | 3 | 37 | 4 | 24 |
GI | 181 | 1 | 52 | 14 | 170 | 29 | 177 |
GU | 437 | 7 | 365 | 36 | 438 | 76 | 463 |
LEUK | 32 | 1 | 52 | 3 | 37 | 5 | 30 |
LUNG | 554 | 9 | 470 | 46 | 560 | 80 | 487 |
LYMPH | 160 | 3 | 157 | 15 | 183 | 29 | 177 |
MELAN | 268 | 2 | 104 | 15 | 183 | 46 | 280 |
MMYEL | 131 | 3 | 157 | 12 | 146 | 29 | 177 |
MULT | 12 | 0 | 0 | 2 | 24 | 7 | 43 |
OTHER | 63 | 1 | 52 | 7 | 85 | 15 | 91 |
PREV | 4 | 0 | 0 | 0 | 0 | 1 | 6 |
SXQOL | 6 | 0 | 0 | 0 | 0 | 2 | 12 |
Total | 2084 | 31 | 1618 | 185 | 2253 | 381 | 2320 |
COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
---|---|---|---|---|---|---|---|
CCD | 791 | 7 | 365 | 63 | 767 | 115 | 700 |
ERLYTX | 10 | 0 | 0 | 1 | 12 | 2 | 12 |
GI | 3 | 0 | 0 | 1 | 12 | 3 | 18 |
GU | 6 | 0 | 0 | 1 | 12 | 5 | 30 |
LUNG | 200 | 3 | 157 | 17 | 207 | 33 | 201 |
OTHER | 9 | 0 | 0 | 1 | 12 | 3 | 18 |
PEOLC | 6 | 0 | 0 | 0 | 0 | 0 | 0 |
PREV | 372 | 3 | 157 | 23 | 280 | 40 | 244 |
SURV | 11 | 0 | 0 | 2 | 24 | 4 | 24 |
SXQOL | 880 | 8 | 417 | 36 | 438 | 60 | 365 |
Total | 2288 | 21 | 1096 | 145 | 1764 | 265 | 1612 |
COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
---|---|---|---|---|---|---|---|
BREAST | 264 | 7 | 365 | 42 | 511 | 79 | 481 |
CCD | 811 | 8 | 417 | 64 | 779 | 121 | 737 |
ERLYTX | 41 | 0 | 0 | 4 | 49 | 6 | 37 |
GI | 188 | 1 | 52 | 17 | 207 | 32 | 195 |
GU | 452 | 5 | 261 | 37 | 450 | 83 | 505 |
LEUK | 32 | 1 | 52 | 3 | 37 | 5 | 30 |
LUNG | 754 | 12 | 626 | 63 | 767 | 113 | 688 |
LYMPH | 160 | 3 | 157 | 15 | 183 | 29 | 177 |
MELAN | 268 | 2 | 104 | 15 | 183 | 46 | 280 |
MMYEL | 133 | 3 | 157 | 13 | 158 | 31 | 189 |
MULT | 15 | 1 | 52 | 3 | 37 | 7 | 43 |
OTHER | 89 | 1 | 52 | 10 | 122 | 21 | 128 |
PEOLC | 6 | 0 | 0 | 0 | 0 | 0 | 0 |
PREV | 376 | 3 | 157 | 23 | 280 | 41 | 250 |
SURV | 11 | 0 | 0 | 2 | 24 | 4 | 24 |
SXQOL | 886 | 8 | 417 | 36 | 438 | 62 | 377 |
Total | 4486 | 55 | 2869 | 347 | 4225 | 680 | 4141 |
COMMITTEE | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
---|---|---|---|---|---|---|---|
BREAST | 284 | 8 | 417 | 42 | 511 | 94 | 572 |
ERLYTX | 35 | 0 | 0 | 5 | 61 | 8 | 49 |
GI | 93 | 0 | 0 | 8 | 97 | 18 | 110 |
GU | 268 | 7 | 365 | 23 | 280 | 43 | 262 |
LEUK | 39 | 2 | 104 | 6 | 73 | 8 | 49 |
LUNG | 774 | 14 | 730 | 68 | 828 | 124 | 755 |
LYMPH | 135 | 3 | 157 | 20 | 244 | 33 | 201 |
MELAN | 9 | 0 | 0 | 0 | 0 | 3 | 18 |
MMYEL | 177 | 3 | 157 | 19 | 231 | 48 | 292 |
MULT | 23 | 1 | 52 | 3 | 37 | 11 | 67 |
Total | 1837 | 38 | 1982 | 194 | 2362 | 390 | 2375 |
Inst. | Accrual Last 12 Months |
Accrual Last 7 Days |
Yearly Projection (7 Days) |
Accrual Last 30 Days |
Yearly Projection (30 Days) |
Accrual Last 60 Days |
Yearly Projection (60 Days) |
---|---|---|---|---|---|---|---|
Member | 1928 | 28 | 1461 | 152 | 1851 | 312 | 1899 |
AFFIL | 242 | 4 | 209 | 25 | 304 | 49 | 298 |
CCOP/NCORP | 2202 | 20 | 1044 | 153 | 1863 | 285 | 1735 |
Non-SWOG | 1783 | 30 | 1565 | 134 | 1631 | 287 | 1747 |
Total | 6155 | 82 | 4279 | 464 | 5649 | 933 | 5679 |
ADMIN | STUDYID | STNAME | REGTYPE | Opened? | Open Date |
---|---|---|---|---|---|
OTHER | EA3161 | HNC, HPV+ OPCA, (cisplatin+RT) +/- Nivo | 1 | E | 22-JUL-24 |
OTHER | EA3161 | HNC, HPV+ OPCA, (cisplatin+RT) +/- Nivo | 2 | E | 22-JUL-24 |
LYMPH | S1608 | FL, TGR-1202/Lenalidomide/CHOP or Benda +Ob | 1 | N | 15-JUL-24 |
BREAST | S1706 | Breast, Inflammatory, RT +/- Olaparib | 1 | N | 01-JUL-24 |
MELAN | EA6174 | Merkel, Adjuvant Pembrolizumab vs Observation | 1 | E | 01-JUL-24 |
ADMIN | STUDYID | STNAME | REGTYPE | Registrations |
---|---|---|---|---|
LUNG | S2302 | NSCLC, Stg IV or Recur, Ramu + Pembro vs SoC | 1 | 11 |
SXQOL | S2010 | ASPEN: Brst, Stg I-III, ASM vs Pt Ed | 1 | 8 |
CCD | S2108CD | Genomic Tumor Board vs Usual Practice | 1 | 7 |
BREAST | S2212 | Breast, TNBC, Neoadj Chemo + Pembro | 1 | 7 |
LUNG | LUNGMAP | NSCLC, Adv, Master | 1 | 6 |
GU | S1802 | Pros, Stg IV, SST +/- Surg/RT to Primary Tum | 1 | 6 |
MELAN | S2015 | MELAN, Stg I-II, 1cm v 2cm excision margins | 1 | 5 |
SXQOL | S2205 | ICE COMPRESS: Reduction of CIPN from Taxanes | 1 | 5 |
BREAST | S2206 | Brst, Stg II-III, MP2, Neoadj Chemo +/- Durva | 1 | 5 |
GI | A022004 | Colon, Stg II-III, Encor+Cetux vs SOC | 0 | 3 |
MMYEL | S1803 | MM, Maintenance, Len vs Len/Dara | 1 | 3 |
MMYEL | S1803 | MM, Maintenance, Len vs Len/Dara | 2 | 3 |
LUNG | S1914 | NSCLC, High Risk Early Stg, SBRT +/- Atezo | 1 | 3 |